Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.962,29
-0,25%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE abrdn Life Sciences Investors (HQL) abrdn Life Sciences Investors (HQL) Notizie

HQL

abrdn Life Sciences Inve... (HQL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:HQL
DataOraFonteTitoloSimboloCompagnia
20/12/202419:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
16/12/202417:48Edgar (US Regulatory)Form N-CEN - Annual Report for Registered Investment CompaniesNYSE:HQLabrdn Life Sciences Investors
09/12/202419:05Edgar (US Regulatory)Form N-CSR - Certified Shareholder ReportNYSE:HQLabrdn Life Sciences Investors
27/11/202416:59Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NYSE:HQLabrdn Life Sciences Investors
27/08/202420:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HQLabrdn Life Sciences Investors
10/06/202420:34Edgar (US Regulatory)Form N-CSRS - Certified Shareholder Report, Semi-AnnualNYSE:HQLabrdn Life Sciences Investors
03/06/202415:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:HQLabrdn Life Sciences Investors
24/05/202415:13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:HQLabrdn Life Sciences Investors
29/12/202313:54Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNYSE:HQLabrdn Life Sciences Investors
27/10/202322:57Business WireTekla Capital Management LLC Announces Closing of Transaction With abrdnNYSE:HQLabrdn Life Sciences Investors
27/10/202322:57Business WireTekla Funds Approve New Investment Advisory Agreements With abrdn Inc.NYSE:HQLabrdn Life Sciences Investors
14/10/202300:26Business WireTekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the FundsNYSE:HQLabrdn Life Sciences Investors
05/10/202320:05Business WireTekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund ExpensesNYSE:HQLabrdn Life Sciences Investors
29/09/202316:35Business WireTekla Life Sciences Investors Paid DistributionNYSE:HQLabrdn Life Sciences Investors
27/09/202315:33Edgar (US Regulatory)Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]NYSE:HQLabrdn Life Sciences Investors
13/09/202314:51Business WireTekla Funds Announce Adjournment of Special Meetings and Implore Shareholders to Vote Their Shares ImmediatelyNYSE:HQLabrdn Life Sciences Investors
12/09/202323:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:HQLabrdn Life Sciences Investors
30/08/202320:39Business WireTekla Funds Announce Second Adjournment of Special Meetings and Urge Shareholder Participation to Limit the Need for Further Solicitation EffortsNYSE:HQLabrdn Life Sciences Investors
25/08/202320:35Edgar (US Regulatory)Form N-CSR/A - Certified Shareholder Report: [Amend]NYSE:HQLabrdn Life Sciences Investors
15/08/202315:55Business WireTekla Life Sciences Investors Declares DistributionNYSE:HQLabrdn Life Sciences Investors
14/08/202321:10Business WireTekla Funds Announce Adjournment of Special MeetingsNYSE:HQLabrdn Life Sciences Investors
04/08/202318:05Edgar (US Regulatory)Form N-PX - Annual Report of proxy voting record of management investment companiesNYSE:HQLabrdn Life Sciences Investors
27/06/202323:07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:HQLabrdn Life Sciences Investors
20/06/202323:48Business WireTekla Capital Management LLC Announces Proposed TransactionNYSE:HQLabrdn Life Sciences Investors
15/05/202320:42Edgar (US Regulatory)Monthly Portfolio Investments Report on Form N-port (public) (nport-p)NYSE:HQLabrdn Life Sciences Investors
11/04/202318:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:HQLabrdn Life Sciences Investors
31/03/202315:55Business WireTekla Healthcare Opportunities Fund Paid DistributionNYSE:HQLabrdn Life Sciences Investors
31/03/202315:55Business WireTekla World Healthcare Fund Paid DistributionNYSE:HQLabrdn Life Sciences Investors
31/03/202315:55Business WireTekla Healthcare Investors Paid DistributionNYSE:HQLabrdn Life Sciences Investors
16/03/202319:40Business WireTekla Life Sciences Investors Announce Renewal of Share Repurchase ProgramNYSE:HQLabrdn Life Sciences Investors
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:HQL

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network